Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
52,866
+25,000
+90% +$70.7K ﹤0.01% 3226
2026
Q1
$67.4K Buy
+27,866
New +$76K ﹤0.01% 3389
2025
Q3
Sell
-30,030
Closed -$86.2K 3649
2025
Q2
$86.2K Buy
+30,030
New +$79.3K ﹤0.01% 3269
2024
Q2
Sell
-11,054
Closed -$71.1K 3218
2024
Q1
$71.1K Buy
+11,054
New +$100K ﹤0.01% 2985

Other funds holding GNLX

Mariner's GNLX Position: Q2 2026 in Review

Mariner increased its Genelux (GNLX) stake by 90% in Q2 2026, buying an estimated $70.7K and bringing the position to 52,866 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #3226.

Mariner first reported a position in GNLX in Q1 2024 and has held it in 4 quarters since. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Mariner held 52,866 shares of Genelux worth $159K as of Q2 2026.
  • Mariner bought 25,000 Genelux shares in Q2 2026, an estimated $70.7K.
  • Genelux made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3226 holding.
  • Mariner first reported a position in Genelux in Q1 2024 and has held it in 4 quarters since.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.